Want to join the conversation?
Alexia Quadrani of JP Morgan asks about upfront pricing and whether $SNI can grow or maintain its premium pricing versus peers. CEO Kenneth Lowe said $SNI is priced at the top of the market and will continue to push that because quality and exclusivity are going to be at a minimum and are going to be priced at the high end of the market.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?